Controversies in OSA: causes and future directions

P. Lévy (Grenoble, France)

Source: Virtual Congress 2021 – What is new for sleep apnoea? The European perspective: findings from the European Sleep Apnoea Database (ESADA)

WebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. Lévy (Grenoble, France). Controversies in OSA: causes and future directions. Virtual Congress 2021 – What is new for sleep apnoea? The European perspective: findings from the European Sleep Apnoea Database (ESADA)

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Future directions: preventing and treating asthma
Source: International Congress 2016 – Childhood wheeze: are we making any progress?
Year: 2016


Current developments and future directions in COPD
Source: Eur Respir Rev, 29 (158) 200289; 10.1183/16000617.0289-2020
Year: 2020



Assessing the worldwide epidemiology of sarcoidosis: challenges and future directions
Source: Eur Respir J 2016; 48: 1545-1548
Year: 2016


Monitoring asthma in children: conclusions and future directions
Source: International Congress 2014 – Monitoring asthma in children: results of the ERS Task Force
Year: 2014



Current developments and future directions in respiratory physiotherapy
Source: Eur Respir Rev, 29 (158) 200264; 10.1183/16000617.0264-2020
Year: 2020



Treatment of interstitial lung diseases: current approaches and future directions
Source: Virtual Congress 2021 – Interstitial lung diseases: from disease mechanisms to novel treatment options
Year: 2021


Sleep apnoea syndrome in 2011: current concepts and future directions
Source: Eur Respir Rev 2011; 20: 134-146
Year: 2011


Filling the gaps: future treatment options for mild asthma
Source: International Congress 2018 – The complexities of managing mild asthma
Year: 2018

What is a COPD exacerbation? Current definitions, pitfalls, challenges and opportunities for improvement
Source: Eur Respir J, 52 (5) 1801261; 10.1183/13993003.01261-2018
Year: 2018



Recommendations of new therapies for severe asthma and the future
Source: Annual Congress 2013 –ERS/ATS Task Force report on severe asthma
Year: 2013


Sleep apnoea and cancer: current insights and future perspectives
Source: Eur Respir J 2012; 40: 1315-1317
Year: 2012


Clinical care for primary ciliary dyskinesia: current challenges and future directions
Source: Eur Respir Rev, 26 (145) 170023; 10.1183/16000617.0023-2017
Year: 2017



Pharmacological options for the treatment of COPD: present and future
Source: Annual Congress 2007 - PG6 - COPD: comprehensive clinical assessment and pharmacological and nonpharmacological therapy
Year: 2007

The overlap between bronchiectasis and chronic airway diseases: state of the art and future directions
Source: Eur Respir J, 52 (3) 1800328; 10.1183/13993003.00328-2018
Year: 2018



Who should receive which biologic and why? Current and future approaches in severe asthma patients
Source: Virtual Congress 2021 – Linking scientific mechanisms to recent clinical therapeutic advances in airway disease: why, who, when and what?
Year: 2021


Management of primary ciliary dyskinesia: current practice and future perspectives
Source: Eur Respir Monogr 2018; 81: 282-299
Year: 2018


Diagnosis of primary ciliary dyskinesia: current practice and future perspectives
Source: Eur Respir Monogr 2018; 81: 267-281
Year: 2018


Bringing it all together: common pathways, emerging therapeutics and future directions
Source: International Congress 2014 – From bench to bronchiole: translational immunology and airways disease
Year: 2014



Current practice and future directions in CSA treatment: positive airway pressure, stimulation and pharmacotherapy
Source: Sleep and Breathing Conference 2021
Year: 2021